Annual report pursuant to Section 13 and 15(d)

Statement of Changes in Stockholder's Equity

v3.21.1
Statement of Changes in Stockholder's Equity - 3 months ended Dec. 31, 2020 - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance – October 15, 2020 (inception) at Oct. 14, 2020 $ 0 $ 0 $ 0 $ 0
Balance – October 15, 2020 (inception), shares at Oct. 14, 2020   0    
Issuance of common stock to Sponsor [1] 25,000 $ 690 24,310  
Issuance of common stock to Sponsor, shares [1]   6,900,000    
Net loss (526)     (526)
Balance – December 31, 2020 at Dec. 31, 2020 $ 24,474 $ 690 $ 24,310 $ (526)
Balance – December 31, 2020, shares at Dec. 31, 2020   6,900,000    
[1] Includes 900,000 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 11, 2021, the Company effected a stock dividend of 1,150,000 shares with respect to the common stock, resulting in an aggregate of 6,900,000 shares of common stock issued and outstanding. All shares and associated amounts have been retroactively restated to reflect the share dividend (see Note 5 and 8). On January 19, 2021, the underwriters exercised the over-allotment option in full. As a result, the 900,000 shares are no longer subject to forfeiture.